Cancer therapies: AI-based image analysis detects early organ damage
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2025 02:11 ET (29-Oct-2025 06:11 GMT/UTC)
A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve throughout the different clinical phases of Hepatitis B virus (HBV) infection. Researchers analyzed liver and blood samples from patients in various clinical phases—acute hepatitis B (AHB), immune tolerant (IT), immune active (IA), and inactive chronic infection (ICI)—using single-cell RNA and TCR/BCR sequencing. The findings highlight critical immune cell subsets and potential molecular mechanisms that drive disease progression, providing valuable targets for the development of future immunomodulatory therapies.